HEALTHPEAK PROPERTIES ($DOC) posted quarterly earnings results for Q4 2025 on Monday, February 2nd. The company reported earnings of $0.47 per share, beating estimates of $0.06 by $0.41. The company also reported revenue of $719,400,000, beating estimates of $698,420,555 by $20,979,445.
Stock price change since market close: -1.06%
You can see Quiver Quantitative's $DOC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
HEALTHPEAK PROPERTIES Insider Trading Activity
HEALTHPEAK PROPERTIES insiders have traded $DOC stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $DOC stock by insiders over the last 6 months:
- SCOTT M BRINKER (President and CEO) purchased 1,490 shares for an estimated $25,076
- JOHN T THOMAS purchased 1,450 shares for an estimated $24,729
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
HEALTHPEAK PROPERTIES Hedge Fund Activity
We have seen 363 institutional investors add shares of HEALTHPEAK PROPERTIES stock to their portfolio, and 370 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 15,024,469 shares (+1489.2%) to their portfolio in Q3 2025, for an estimated $287,718,581
- JPMORGAN CHASE & CO added 8,212,504 shares (+41.0%) to their portfolio in Q3 2025, for an estimated $157,269,451
- INVESCO LTD. removed 4,653,259 shares (-21.8%) from their portfolio in Q3 2025, for an estimated $89,109,909
- EQUITY INVESTMENT CORP added 3,608,849 shares (+209.6%) to their portfolio in Q3 2025, for an estimated $69,109,458
- RESOLUTION CAPITAL LTD removed 3,537,527 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $67,743,642
- BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC added 3,384,904 shares (+inf%) to their portfolio in Q3 2025, for an estimated $64,820,911
- AMERIPRISE FINANCIAL INC removed 3,035,852 shares (-53.3%) from their portfolio in Q3 2025, for an estimated $58,136,565
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HEALTHPEAK PROPERTIES Congressional Stock Trading
Members of Congress have traded $DOC stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $DOC stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 08/04.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
HEALTHPEAK PROPERTIES Analyst Ratings
Wall Street analysts have issued reports on $DOC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Raymond James issued a "Outperform" rating on 09/15/2025
- Morgan Stanley issued a "Overweight" rating on 08/22/2025
To track analyst ratings and price targets for HEALTHPEAK PROPERTIES, check out Quiver Quantitative's $DOC forecast page.
HEALTHPEAK PROPERTIES Price Targets
Multiple analysts have issued price targets for $DOC recently. We have seen 9 analysts offer price targets for $DOC in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- John Kilichowski from Wells Fargo set a target price of $18.0 on 02/02/2026
- Julien Blouin from Goldman Sachs set a target price of $17.0 on 01/09/2026
- Jonathan Petersen from Jefferies set a target price of $17.0 on 12/16/2025
- James Kammert from Evercore ISI Group set a target price of $21.0 on 12/15/2025
- Amanda Sweitzer from Baird set a target price of $20.0 on 11/12/2025
- Richard Anderson from Cantor Fitzgerald set a target price of $20.0 on 10/01/2025
- Jonathan Hughes from Raymond James set a target price of $20.0 on 09/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
